LIAN News

November kicked off with a 12 IPO week and shoe brand Allbirds (BIRD) was at the front of the flock, posting a first-day pop of 93%. 23 SPACs also went public. New issuers continued to join the pipeline, with five IPOs and 13 SPACs submitting initial filings. Two issuers postponed this past week: Russian car-sharing firm Delimobil (DMOB) and...read more

LianBio, which is developing in-licensed therapies for a variety of indications in China, raised $325 million by offering 20.3 million ADSs at $16, within the range of $15 to $17. LianBio is focused on the in-licensing, development, and commercialization of therapeutics in Greater China, including Mainland China, Hong Kong, Taiwan, Macau, and other Asian markets. The company...read more

Updated Monday, 11/1. The IPO market has seen double digit offerings for the past two weeks, and is scheduled to continue its streak, with 13 IPOs expected to raise $2.7 billion. Drug discovery company Evotec (EVO) plans to raise $576 million at a $9.2 billion market cap. The company aims to accelerate and improve the efficiency of the drug discovery...read more

Updated Monday, 10/25. The IPO market continues to stay busy with 15 IPOs schedule to raise $7.2 billion in the week ahead.   Semiconductor foundry GlobalFoundries (GFS) plans to raise $2.4 billion at a $24.6 billion market cap. Backed by Abu Dhabi’s Mubadala, US-based GlobalFoundries is one of the world’s leading specialty...read more